Bayer is a global enterprise with core competencies in the fields of health care, agriculture and high-tech materials. Founded in 1863, the Group employs about 112,000 people worldwide. As an inventor company, it sets trends in research-intensive areas. Bayer’s products and services are designed to benefit people and improve the quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is represented around the world by about 300 companies and its headquarters is located in Leverkusen, Germany.
Business operations are the responsibility of the subgroups:
Bayer HealthCare is among the world’s foremost innovators in the field of pharmaceutical and medical products.
Bayer CropScience, with its highly effective products, pioneering innovations and keen customer focus, holds global leadership positions in crop protection and non-agricultural pest control.
Bayer MaterialScience is a renowned supplier of high-performance materials such as polycarbonates and polyurethanes, and innovative system solutions for a wide range of everyday uses. » more
Central service functions are combined into three service companies:
Bayer Business Services is the Bayer Group’s international competence center for IT-based services.
Bayer Technology Services is the global technological backbone for the Bayer Group and a major innovation driver.
Currenta offers services for the chemical industry including utility supply, waste management, infrastructure, safety, security, analytics and vocational training.
The Bayer Group markets some 5,000 products. Best-sellers include:
Health care: Betaferon™/Betaseron™, Yasmin™/YAZ™/Yasminelle™, Kogenate™
Agriculture: Confidor™/ Gaucho™/Admire™/Merit™, Flint™/Stratego™/Sphere™/Nativo™
High-tech materials: Makrolon™, Bayblend™, Desmodur™, Desmophen™
Bayer is committed to the principles of sustainable development and acts as a socially and ethically responsible corporate citizen. In fiscal 2011, the Group had sales of €36.5 billion and its capital expenditures amounted to €1.7 billion and R&D expenses to €2.9 billion.See more